Revenue | ₹3.14Cr |
Net Profits | ₹0.14Cr |
Net Profit Margins | 4.46% |
Ishita Drugs & Industries Ltd’s revenue fell -5.42% since last year same period to ₹3.14Cr in the Q2 2025-2026. On a quarterly growth basis, Ishita Drugs & Industries Ltd has generated -42.81% fall in its revenue since last 3-months.
Ishita Drugs & Industries Ltd’s net profit fell -26.32% since last year same period to ₹0.14Cr in the Q2 2025-2026. On a quarterly growth basis, Ishita Drugs & Industries Ltd has generated -53.33% fall in its net profits since last 3-months.
Ishita Drugs & Industries Ltd’s net profit margin fell -22.09% since last year same period to 4.46% in the Q2 2025-2026. On a quarterly growth basis, Ishita Drugs & Industries Ltd has generated -18.41% fall in its net profit margins since last 3-months.
The revenue for Ishita Drugs & Industries Ltd in the Q2 results 2025 was ₹3.14Cr.
The net profit for Ishita Drugs & Industries Ltd in the Q2 results 2025 was ₹0.14Cr.
The net profit margin for Ishita Drugs & Industries Ltd in the Q2 results 2025 was 4.46%.
The revenue for Ishita Drugs & Industries Ltd in the Q2 results 2024 was ₹3.32Cr.
The net profit for Ishita Drugs & Industries Ltd in the Q2 results 2024 was ₹0.19Cr.
The net profit margin for Ishita Drugs & Industries Ltd in the Q2 results 2024 was 5.72%.